Top 20 Companies in Global Brachytherapy Devices Market (2026–2035): Spherical Insights Analysis

Description

According to a research report published by Spherical Insights & Consulting, The Global Brachytherapy Devices Market Size Is Projected To Grow From USD 1.30 Billion In 2025 To USD 2.98 Billion By 2035, At A CAGR Of 8.65% During The Forecast Period 2026–2035. The market is expanding because of three factors, which include the increasing global cancer burden, the growing use of minimally invasive radiation treatments, and the development of new technologies that use image guidance and AI-powered brachytherapy systems.

 

Introduction

The brachytherapy devices market includes the development, manufacturing, and distribution of medical devices that people use to perform internal radiation therapy. The medical devices that are part of this market category include applicators, afterloaders, seeds, and electronic brachytherapy systems. In 2025, the world experienced rising cancer rates, which created a greater need for cancer treatment solutions which began. According to industry data, more than 2 million new cancer cases emerge every year in major markets, which creates demand for localized cancer treatments such as brachytherapy. Healthcare organizations and governments allocate funds to build advanced radiotherapy systems which will enhance cancer treatment accessibility. Both India and China, as emerging economies, are building new oncology centers while they implement advanced radiation treatment systems.

 

The U.S. FDA and international radiotherapy bodies work to establish guidelines that enable research in artificial intelligence-based brachytherapy systems while their development improves treatment accuracy and patient safety. The primary market expansion possibilities come from scientists who created MRI-compatible applicators, doctors who started using real-time imaging systems, and outpatient facilities that began using high-dose-rate (HDR) brachytherapy.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brachytherapy Devices Market.

 

Brachytherapy Devices Market Size & Statistics

• The Market Size for Brachytherapy Devices Was Estimated to be worth USD 1.30 Billion in 2025.
• The Market is Going to Expand at a CAGR of 8.65% between 2026 and 2035.
• The Global Brachytherapy Devices Market Size is anticipated to reach USD 2.98 Billion by 2035.
• North America is expected to generate the largest demand during the forecast period in the Brachytherapy Devices Market.
• Asia Pacific is expected to grow the fastest during the forecast period in the Brachytherapy Devices Market.

 

Market Segmentation:

Global Brachytherapy Devices Market Size, Share, By Product (Brachytherapy Afterloader, Brachytherapy Applicators, and Others), By Applications (Prostate Cancer, Cervical Cancer, Breast Cancer, Gynecological Cancer, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2026 - 2035

 

Regional growth and demand

Asia Pacific is expected to grow the fastest during the forecast period in the brachytherapy devices market. In 2025, healthcare providers in the region increased their usage of advanced brachytherapy systems because it helped them achieve better treatment accuracy and more accessible treatment options. The Asia Pacific is expected to grow the fastest due to expanding healthcare infrastructure, increasing cancer incidence, and rising government investments in oncology care. Countries like India, China, and Japan are strengthening radiotherapy capabilities.

 

North America is expected to generate the largest demand during the forecast period in the brachytherapy devices market. In 2025, the United States leads in brachytherapy adoption because there exists both reimbursement policies and a workforce of trained professionals who can deliver this treatment. The region held more than 44 percent of the worldwide market share. North America dominates the market due to advanced healthcare systems, high cancer diagnosis rates, and strong adoption of innovative treatment technologies.

 

 

Top 10 Trends in the Brachytherapy Devices Market

1. Rising adoption of minimally invasive cancer treatments
2. Increasing use of high-dose-rate (HDR) brachytherapy
3. Integration of AI in treatment planning
4. Growth of image-guided brachytherapy
5. Development of MRI-compatible applicators
6. Expansion of outpatient cancer treatment centers
7. Increasing demand for personalized oncology treatments
8. Technological advancements in radioactive isotopes
9. Growth in emerging healthcare markets
10. Focus on reducing treatment time and side effects

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brachytherapy Devices Market.

 

1.Rising adoption of minimally invasive treatments

Brachytherapy offers targeted radiation with minimal damage to surrounding tissues, making it a preferred option for cancer treatment.

 

2.Increasing use of HDR brachytherapy

HDR techniques enable faster treatment sessions and improved patient outcomes, driving widespread adoption across oncology centers.

 

3.Integration of AI in treatment planning

AI-based systems improve precision, reduce errors, and enhance efficiency in radiation dose delivery and treatment planning.

 

4.Growth of image-guided brachytherapy

Advanced imaging technologies improve accuracy in device placement and radiation targeting, enhancing clinical outcomes.

 

5.Development of MRI-compatible applicators

Modern applicators designed for MRI compatibility improve visualization and treatment precision, boosting adoption.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the brachytherapy devices market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 20 Companies Leading the Brachytherapy Devices Market

1. Elekta AB
2. Varian Medical Systems
3. Eckert & Ziegler
4. Becton Dickinson and Company
5. IsoRay Inc.
6. Theragenics Corporation
7. Best Medical International
8. CIVCO Medical Solutions
9. Argon Medical Devices
10. Panacea Medical Technologies
11. iCAD Inc.
12. Ion Beam Applications
13. Oncura Inc.
14. Proxima Therapeutics
15. Nucletron
16. Isoray Medical
17. Shanghai Atom High-Tech
18. Alpha Tau Medical
19. GE Healthcare
20. Siemens Healthineers

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brachytherapy Devices Market.

 

1.Elekta AB

Headquarters: Stockholm, Sweden

Elekta AB was founded in 1972 by Lars Leksell and is led by CEO Gustaf Salford. The company is a global leader in radiation therapy solutions, including brachytherapy systems such as afterloaders and treatment planning software. Elekta employs over 4,500 people worldwide and reported approximately USD 1.7 billion in 2025 revenue. It operates in more than 120 countries, with a strong presence in Europe, North America, and the Asia-Pacific. The company focuses on precision radiation medicine, AI-driven oncology solutions, and integrated cancer care systems, supporting hospitals in improving treatment accuracy and patient outcomes.

 

2.Varian Medical Systems

Headquarters: California, USA

Varian Medical Systems, founded in 1948 and now part of Siemens Healthineers, is led by CEO Dow Wilson (division). The company specializes in advanced cancer treatment technologies, including brachytherapy devices and software. It employs thousands globally and contributes significantly to Siemens Healthineers’ revenue, which exceeded USD 25 billion in 2025. Varian operates in over 100 countries, with key markets in the United States, Europe, and Asia. The company focuses on integrating imaging, software, and radiotherapy systems to improve cancer treatment precision and enhance clinical outcomes.

 

3.Eckert & Ziegler

Headquarters: Berlin, Germany

Eckert & Ziegler was founded in 1997 and is led by CEO Andreas Eckert. The company specializes in isotope technology and provides radioactive sources used in brachytherapy treatments. It employs over 1,000 people globally and reported approximately USD 300 million in 2025 revenue. The company operates in more than 50 countries, with a strong presence in Europe and North America. Eckert & Ziegler focuses on radiopharmaceuticals, isotope production, and radiation therapy components, supporting cancer treatment centers with reliable and high-quality radioactive materials.

 

4.Becton Dickinson and Company

Headquarters: New Jersey, USA

Becton Dickinson and Company (BD) was founded in 1897 and is led by CEO Tom Polen. The company provides medical devices, including brachytherapy needles and delivery systems. BD employs over 75,000 people worldwide and reported approximately USD 21 billion in 2025 revenue. It operates in more than 190 countries, with a strong presence in the United States, Europe, and Asia. The company focuses on medical innovation, patient safety, and improving healthcare delivery through advanced technologies used in oncology and minimally invasive procedures.

 

5.IsoRay Inc.

Headquarters: Washington, USA

IsoRay Inc. was founded in 2004 and specializes in brachytherapy solutions, particularly cesium-131 isotope seeds used in cancer treatment. The company operates primarily in the United States and focuses on targeted radiation therapies. IsoRay employs a smaller workforce and generates modest revenue compared to large players but is recognized for innovation in isotope-based treatments. The company emphasizes precision oncology, improved patient outcomes, and expanding clinical applications of its proprietary isotope technology.

 

Are you ready to discover more about the brachytherapy devices market?

The report provides an in-depth analysis of the leading companies operating in the global brachytherapy devices market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Elekta AB

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

1. Varian Medical Systems
2. Eckert & Ziegler
3. Becton Dickinson and Company
4. IsoRay Inc.
5. Theragenics Corporation
6. Best Medical International
7. CIVCO Medical Solutions
8. Argon Medical Devices
9. Others

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Brachytherapy Devices Market.

 

Conclusion

The global brachytherapy devices market is expected to witness steady growth through 2035, which will result from increasing cancer rates, improvements in radiation therapy technologies, and the growing need for less invasive medical procedures. Brachytherapy delivers essential treatment to oncology patients through its ability to deliver focused radiation, which results in faster treatment times and better results for patients. The market is benefiting from trends such as AI integration, image-guided therapy, and personalized medicine approaches. North America holds the top market position because of its developed infrastructure and high technology usage, while the Asia Pacific emerges as the fastest-growing market section through its growing healthcare spending and rising public understanding of cancer. Elekta AB, Varian Medical Systems, and other top companies lead their industries through research and development work, strategic partnership deals, and new product creation to build stronger market positions, which help them provide advanced cancer treatment solutions to their customers.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter